Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
2.21 USD -1.78% Intraday chart for Regulus Therapeutics Inc. -16.60% +72.66%
05-09 Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Regulus Therapeutics Advances to Cohort 4 of Phase 1B Multiple-Ascending Dose Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease CI
b6b99367ce1f4ea3f33db3e63f90af73.P7HB1MMBZHSeJd2FTfTIUrvtTexhRHgFvyrYJjXhwos.coWy5KdmIAD_EJLnCKP9FOO9fpYzMi1c9ViHXFGj8OR2g_axj3EMHO1R7Q~26648ace0808300811603a4bc2510d01
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Charts Regulus Therapeutics Inc.
  5. News Chart